English  |  正體中文  |  简体中文  |  2825920  
???header.visitor??? :  31401648    ???header.onlineuser??? :  1203
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"yen shen lu"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 51-75 of 149  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2020-05-25T06:52:08Z Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients Su W.-P;Wen C.-C;Hsiung C.A;Su I.-J;Cheng A.-L;Chang M.-C;Tsao C.-J;Kao W.-Y;Uen W.-C;Hsu C.-H;Yen-Shen Lu;Tien H.-F;Chao T.-Y;Chen L.-T;Whang-Peng J;Chen P.-J.; Su W.-P; Wen C.-C; Hsiung C.A; Su I.-J; Cheng A.-L; Chang M.-C; Tsao C.-J; Kao W.-Y; Uen W.-C; Hsu C.-H; YEN-SHEN LU; Tien H.-F; Chao T.-Y; Chen L.-T; Whang-Peng J; Chen P.-J.
臺大學術典藏 2020-05-25T06:52:07Z Efficacy of a novel histone deacetylase inhibitor in murine models of hepatocellular carcinoma Wang Y.-C; Wang D; Hung J.-H; Tang M; Lin Z.-Z; Chen T.-J; Cheng A.-L; Chen C.-S.; Yen-Shen Lu;Kashida Y;Kulp S.K;Wang Y.-C;Wang D;Hung J.-H;Tang M;Lin Z.-Z;Chen T.-J;Cheng A.-L;Chen C.-S.; YEN-SHEN LU; Kashida Y; Kulp S.K
臺大學術典藏 2020-05-25T06:52:07Z Glucocorticoid receptor expression in advanced non-small cell lung cancer: clinicopathological correlation and in vitro effect of glucocorticoid on cell growth and chemosensitivity Yen-Shen Lu;Lien H.-C;Yeh P.-Y;Kuo S.-H;Chang W.-C;Kuo M.-L;Cheng A.-L.; YEN-SHEN LU; Lien H.-C; Yeh P.-Y; Kuo S.-H; Chang W.-C; Kuo M.-L; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:07Z Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms Lien H.-C;Yen-Shen Lu;Cheng A.-L;Chang W.-C;Jeng Y.-M;Kuo Y.-H;Huang C.-S;Chang K.-J;Yao Y.-T.; Lien H.-C; YEN-SHEN LU; Cheng A.-L; Chang W.-C; Jeng Y.-M; Kuo Y.-H; Huang C.-S; Chang K.-J; Yao Y.-T.
臺大學術典藏 2020-05-25T06:52:07Z A phase II trial of weekly paclitaxel and high-dose 5-fluorouracil plus leucovorin in patients with chemotherapy-pretreated metastatic breast cancer Lin C.-C;Cheng A.-L;Hsu C.-H;Yen-Shen Lu;Hsu C;Yeh K.-H;Wu C.-Y;Huang C.-S;Yang C.-H.; Lin C.-C; Cheng A.-L; Hsu C.-H; YEN-SHEN LU; Hsu C; Yeh K.-H; Wu C.-Y; Huang C.-S; Yang C.-H.
臺大學術典藏 2020-05-25T06:52:06Z Differential expression of glucocorticoid receptor in carcinomas of the human digestive system Cheng A.-L.;Chang W.-C;Yao Y.-T;Shun C.-T;Yen-Shen Lu;Lien H.-C; Lien H.-C; YEN-SHEN LU; Shun C.-T; Yao Y.-T; Chang W.-C; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:06Z Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation Chen C.-S; Wang Y.-C; Yang H.-C; Huang P.-H; Kulp S.K; Yang C.-C; Yen-Shen Lu; Matsuyama S; Chen C.-Y; Chen C.-S.
臺大學術典藏 2020-05-25T06:52:06Z Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation Chen C.-S;Wang Y.-C;Yang H.-C;Huang P.-H;Kulp S.K;Yang C.-C;Yen-Shen Lu;Matsuyama S;Chen C.-Y;Chen C.-S.; Chen C.-S; Wang Y.-C; Yang H.-C; Huang P.-H; Kulp S.K; Yang C.-C; YEN-SHEN LU; Matsuyama S; Chen C.-Y; Chen C.-S.
臺大學術典藏 2020-05-25T06:52:06Z Pneumatosis coli after etoposide chemotherapy for breast cancer Shih I.-L;Yen-Shen Lu;Wang H.-P;Liu K.-L.; Shih I.-L; YEN-SHEN LU; Wang H.-P; Liu K.-L.
臺大學術典藏 2020-05-25T06:52:06Z Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I-II and operable stage III Taiwanese breast cancer patients Huang C.-S.;Chen T.-Z;Lin C.-H;Yen-Shen Lu;You S.-L;Lien H.-C;Kuo S.-H; Kuo S.-H; Lien H.-C; You S.-L; YEN-SHEN LU; Lin C.-H; Chen T.-Z; Huang C.-S.
臺大學術典藏 2020-05-25T06:52:05Z NF-�eB p50 promotes tumor cell invasion through negative regulation of invasion suppressor gene CRMP-1 in human lung adenocarcinoma cells Cheng A.-L.;Kuo M.-L;Chang W.C;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Chang W.C; Kuo M.-L; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:05Z The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers Chang K.-J.;Yen-Shen Lu;Lin C.-H;Shen C.-Y;You S.-L;Yang S.-Y;Lien H.-C;Kuo S.-H;Huang C.-S; Huang C.-S; Kuo S.-H; Lien H.-C; Yang S.-Y; You S.-L; Shen C.-Y; Lin C.-H; YEN-SHEN LU; Chang K.-J.
臺大學術典藏 2020-05-25T06:52:05Z FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C �_ signaling Chen C.-S.;Cheng A.-L;Byrd J.C;Muthusamy N;Kulp S.K;Wang D.-S;Ma Y.-H;Wang Y.-C;Yen-Shen Lu;Hung J.-H; Hung J.-H; YEN-SHEN LU; Wang Y.-C; Ma Y.-H; Wang D.-S; Kulp S.K; Muthusamy N; Byrd J.C; Cheng A.-L; Chen C.-S.
臺大學術典藏 2020-05-25T06:52:04Z Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia Cheng A.-L.;Chang K.-J;Kuo W.-H;Liu J.M;Lan C;Kuo S.-H;Shen Y.-C;Kuo K.-T;Lee W.-C;Huang C.-S;Yen-Shen Lu;Liau J.-Y;Lin C.-H; Lin C.-H; Liau J.-Y; YEN-SHEN LU; Huang C.-S; Lee W.-C; Kuo K.-T; Shen Y.-C; Kuo S.-H; Lan C; Liu J.M; Kuo W.-H; Chang K.-J; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:04Z Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway Chen P.-J; Cheng A.-L.; Hsieh H.-P; YEN-SHEN LU; Hsu C.-H; Hsu C; Yeh P.-Y; Cheng A.-L.;Chen P.-J;Hsieh H.-P;Yen-Shen Lu;Hsu C.-H;Hsu C;Yeh P.-Y;Chen K.-F; Chen K.-F
臺大學術典藏 2020-05-25T06:52:04Z OSU-03012, a novel celecoxib derivative, induces reactive oxygen species-related autophagy in hepatocellular carcinoma Cheng A.-L.;Kuo M.-L;Chen C.-S;Feng W.-C;Lee W.-C;Chen K.-F;Hsu C.-H;Yen-Shen Lu;Yeh P.Y;Gao M; Gao M; Yeh P.Y; YEN-SHEN LU; Hsu C.-H; Chen K.-F; Lee W.-C; Feng W.-C; Chen C.-S; Kuo M.-L; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:04Z Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma Cheng A.-L.;Hsu C;Yen-Shen Lu;Wang D.-S;Fan H.-H;Yu S.-L;Liou J.-Y;Liang J.-D;Shen Y.-C;Ou D.-L; Ou D.-L; Shen Y.-C; Liang J.-D; Liou J.-Y; Yu S.-L; Fan H.-H; Wang D.-S; YEN-SHEN LU; Hsu C; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:03Z Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin Cheng A.-L.; Lin C.-H; Chang K.-J; Kuo W.-H; Hsu C; Lee W.-C; Liau J.-Y; Huang C.-S; Shao Y.-Y;Kuo K.-T;Hu F.-C;Yen-Shen Lu;Huang C.-S;Liau J.-Y;Lee W.-C;Hsu C;Kuo W.-H;Chang K.-J;Lin C.-H;Cheng A.-L.; Shao Y.-Y; Kuo K.-T; Hu F.-C; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:52:03Z Locoregional therapy improves survival for metastatic breast cancer patients? Benefit remains questionable! Yen-Shen Lu;Lin C.-H;Chang D.-Y; Chang D.-Y; Lin C.-H; YEN-SHEN LU
臺大學術典藏 2020-05-25T06:52:03Z Management of HER2-positive breast cancer in Asia: consensus statement from the Asian Oncology Summit 2009 Pritchard K.I.;Shao Z.-M;Voravud N;Yen-Shen Lu;Yip C.H;Ang P.T;Khoo K.S;Anderson B.O;Wong N.S; Wong N.S; Anderson B.O; Khoo K.S; Ang P.T; Yip C.H; YEN-SHEN LU; Voravud N; Shao Z.-M; Pritchard K.I.
臺大學術典藏 2020-05-25T06:52:02Z Unique features of breast cancer in Asian women-Breast cancer in Taiwan as an example Huang C.-S;Lin C.-H;Yen-Shen Lu;Shen C.-Y.; Huang C.-S; Lin C.-H; YEN-SHEN LU; Shen C.-Y.
臺大學術典藏 2020-05-25T06:52:02Z O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers Wu P.-F;Kuo K.-T;Kuo L.-T;Lin Y.-T;Lee W.-C;Yen-Shen Lu;Yang C.-H;Wu R.-M;Tu Y.-K;Tasi J.-C;Tseng H.-M;Tseng S.-H;Cheng A.-L;Lin C.-H.; Wu P.-F; Kuo K.-T; Kuo L.-T; Lin Y.-T; Lee W.-C; YEN-SHEN LU; Yang C.-H; Wu R.-M; Tu Y.-K; Tasi J.-C; Tseng H.-M; Tseng S.-H; Cheng A.-L; Lin C.-H.
臺大學術典藏 2020-05-25T06:52:01Z Combinations of mTORC1 inhibitor RAD001 with gemcitabine and paclitaxel for treating non-Hodgkin lymphoma Chiang C.-T;Yeh P.-Y;Gao M;Chen C.-W;Yeh L.-C;Feng W.-C;Kuo S.-H;Hsu C.-H;Yen-Shen Lu;Cheng A.-L.; Chiang C.-T; Yeh P.-Y; Gao M; Chen C.-W; Yeh L.-C; Feng W.-C; Kuo S.-H; Hsu C.-H; YEN-SHEN LU; Cheng A.-L.
臺大學術典藏 2020-05-25T06:52:01Z Management of ErbB2-positive breast cancer: Insights from preclinical and clinical studies with lapatinib Vogel C;Chan A;Gril B;Kim S.-B;Kurebayashi J;Liu L;Yen-Shen Lu;Moon H.; Vogel C; Chan A; Gril B; Kim S.-B; Kurebayashi J; Liu L; YEN-SHEN LU; Moon H.
臺大學術典藏 2020-05-25T06:52:01Z The prevalence and assessment of ErbB2-positive breast cancer in Asia: A literature survey Tan Y.O;Han S;Yen-Shen Lu;Yip C.-H;Sunpaweravong P;Jeong J;Caguioa P.B;Aggarwal S;Yeoh E.M;Moon H.; Tan Y.O; Han S; YEN-SHEN LU; Yip C.-H; Sunpaweravong P; Jeong J; Caguioa P.B; Aggarwal S; Yeoh E.M; Moon H.

Showing items 51-75 of 149  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page